You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Iodine-124: Target and Production Business
SBC: 3D Imaging Drug Design and Development, LLC Topic: N/ADESCRIPTION (provided by applicant): It is proposed to develop a target for production of iodine-124 for commercial distribution and to develop a radiolabeling business for I-124 radiotracers. I-124 is an increasingly useful nuclide for positron emission t omography, especially to label molecules, such as antibodies or other macromolecules including nanoparticles, that require long-duration experi ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Development of a blood test for breast cancer detection
SBC: INTEGRATED TECHNOLOGIES AND SRVCS INTRNTL Topic: N/ADESCRIPTION (provided by applicant): Mammography is the benchmark for breast disease detection and diagnosis. However, it can miss 10-15% of early stage breast cancers, and it is unable to distinguish between benign and malignant lesions with certainty. Av ailability of an alternate method e.g. biomarker based, which allows early detection/precise distinction between benign disease and breast canc ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Sphingosine Kinase Inhibitors as Anti-Arthritis Agents
SBC: Apogee Biotechnology Corporation Topic: N/ADESCRIPTION (provided by applicant): Sphingolipids are being increasingly recognized as key mediators of inflammatory cascades of critical importance in multiple diseases, including rheumatoid arthritis and osteoarthritis. Most importantly, sphingosine 1-phosphate produced by sphingosine kinase (SK) mediates the effects of tumor necrosis factor-1 and interleukin-12, pro-inflammatory cytokines ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Development of Radiopharmaceuticals for Imaging Brain Tau Pathology
SBC: AVID RADIOPHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical management of AD is complicated by lack of effective meth ods for early and accurate diagnosis of the disease. Thus, there is a significant unmet need for Alzheimer's disease diagnostic tools. The hypo ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia
SBC: AVID RADIOPHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Dementia, with its most prevalent subforms Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia, is a very substantial medical and societal problem. The emergence of many drugs and drug can didates that interfere with the disease mechanism of specific types of dementia makes it crucial to distinguish early between the various forms ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment
SBC: AVID RADIOPHARMACEUTICALS, INC. Topic: N/ADESCRIPTION (provided by applicant): Dementia associated with PD (PDD) is common (affecting up to 80% of patients long-term) and highly disabling. Informative biomarkers are urgently needed to understand the pathology of PDD, to improve the early detection of cognitive deficits and to facilitate the development of treatments for PDD. Nuclear imaging technologies have the potential to produce such ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Monolithic Reagentless Biosensor for Online Monitoring of Waterborne Pathogens
SBC: Biodetection Instruments, Inc Topic: N/ADESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project will develop a reagentless biosensor for online monitoring of microbial contaminants in drinking water. The biosensor is based on incorporating several newly emerg ing technologies into BioDetection Instruments' proprietary sensing platform. A novel monolithic column will be developed that encapsulates a u ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
A Microfluidic Biochip for Rapid Screening of Pesticide Residues
SBC: Biodetection Instruments, Inc Topic: N/ADESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project will develop an innovative biochip for rapid screening of pesticide residues in water and food samples. The proposed biochip will be built on BioDetection Instrume nts' exclusively-licensed patented technology and previous work on biosensors that are based on microfluidics, interdigitated microelectrodes ( ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Nanochannel Devices for High Throughput Single Molecule DNA mapping and Haplotypi
SBC: BIONANOMATRIX, INC. Topic: N/ADESCRIPTION (provided by applicant): The long term objective of this proposal is to develop a fully integrated nanochannel chip and reader capable of single molecule mapping of linearized, long genomic material. The anticipated embodiment will permit dire ct visualization and analysis of megabase fragments of DNA extracted directly from a sample (possibly a single cell) with sub-kilobase resoluti ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Design and development of a bioresorbable bone graft
SBC: CarMell Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): The long-term goal of this project is to develop a safe, cost-effective, off-the-shelf, and well characterized bone filler material based on plastics derived from blood byproducts. Over 800,000 bone procedures are perfo rmed in the US per year, and with the aging US population, this number will only continue to grow. However, current materials, including autogr ...
SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health